With a clinical trial and 'plug-and-play' tech, Rochester's Vyriad wants to advance blood cancer care

Existing CAR-T therapies take some of a patient's immune cells and transform them into cancer-fighting cells, a weekslong, out-of-body process. Vyriad wants that change to take place inside the body.